Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 3, 2023
- Accession no.
- 0001415889-23-005807
- Filed
- Apr 3, 2023
- Trade date
- Mar 31, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.77M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −1,040 | $218.94F2 | −$227,697.6 | 7,090 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −1,906 | $220.04F3 | −$419,396.24 | 5,184 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −861 | $222.12F4 | −$191,245.32 | 4,323 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −1,873 | $223.22F5 | −$418,091.06 | 2,450 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −1,087 | $223.88F6 | −$243,357.56 | 1,363 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −1,233 | $220.93F7 | −$272,406.69 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 168,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $218.44 to $219.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $219.455 to $220.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $221.595 to $222.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $222.605 to $223.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $223.61 to $224.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $220.465 to $221.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.